Healthscore 486·5 metrosupdated 2h ago
Novo Nordisk Sues Eli Lilly Over Deceptive Advertising Claims
Novo Nordisk has filed a lawsuit against Eli Lilly, claiming that the latter's advertisements for its weight-loss drug Zepbound are misleading. The lawsuit argues that Eli Lilly's claims about Zepbound's effectiveness compared to Wegovy are based on outdated trials and mislead consumers about the drugs' efficacy.
Where it's breaking
Local coverage
Novo Nordisk Sues Eli Lilly Over False Advertising Claims
Novo Nordisk Sues Eli Lilly Over Deceptive Weight-Loss Drug Ads
Novo Nordisk Sues Eli Lilly Over Deceptive Advertising Claims
Novo Nordisk Sues Eli Lilly Over Deceptive Weight-Loss Drug Ads
Novo Nordisk Sues Eli Lilly Over Deceptive Advertising Claims
Novo Nordisk Sues Eli Lilly Over Deceptive Advertising Claims
Ask Eli: The housing affordability conversation needs to change
‘Deliberately false’ and ‘outdated’: Eli Lilly slammed with lawsuit over weight-loss drug ads
Sources cited
Original outlets that filed on this story across the contributing metros. Click through for the underlying coverage.
What this is
A national rollup is a story Executive Producer detected breaking in multiple US metros at once. Each contributing market has its own deduplicated cluster from local broadcast, print, government, and community sources — this page links them together so a journalist can see the full national footprint. We are a pointer, not a publisher.Every linked headline goes back to the local cluster and from there to the original outlet — that's the URL to cite. A lead, not the law.